Literature DB >> 10577134

The effects of vancomycin and beta-lactam antibiotics on vancomycin-resistant Staphylococcus aureus.

I Haraga, S Nomura, A Nagayama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10577134     DOI: 10.1056/NEJM199911183412117

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Staphylococcus heterogeneously resistant to vancomycin in China and antimicrobial activities of imipenem and vancomycin in combination against it.

Authors:  Wu Benquan; Tang Yingchun; Zhang Kouxing; Zhang Tiantuo; Zhu Jiaxing; Tan Shuqing
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.

Authors:  Katsuhiro Miura; Masaru Nakagawa; Hiromichi Takahashi; Yoshihito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Masashi Sakagami; Shimon Ohtake; Sumiko Kobayashi; Atsuko Hojo; Daisuke Kurita; Yujin Kobayashi; Machiko Kusuda; Yukio Hirabayashi; Yoshihiro Hatta; Masami Takei
Journal:  Int J Hematol       Date:  2015-12-29       Impact factor: 2.490

3.  Unstable vancomycin heteroresistance is common among clinical isolates of methiciliin-resistant Staphylococcus aureus.

Authors:  Nottasorn Plipat; Gilat Livni; Heidi Bertram; Richard B Thomson
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

4.  First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.

Authors:  S Trakulsomboon; S Danchaivijitr; Y Rongrungruang; C Dhiraputra; W Susaemgrat; T Ito; K Hiramatsu
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin.

Authors:  N Aritaka; H Hanaki; L Cui; K Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

6.  Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit.

Authors:  Wil C Van Der Zwet; Yvette J Debets-Ossenkopp; Erik Reinders; Maria Kapi; Paul H M Savelkoul; Ruurd M Van Elburg; Keiichi Hiramatsu; Christina M J E Vandenbroucke-Grauls
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

7.  Synergy of β-Lactams with Vancomycin against Methicillin-Resistant Staphylococcus aureus: Correlation of Disk Diffusion and Checkerboard Methods.

Authors:  Cheng Len Sy; Tsi-Shu Huang; Chii Shiang Chen; Yao-Shen Chen; Hung-Chin Tsai; Shue-Renn Wann; Kuan-Sheng Wu; Jui-Kuang Chen; Susan Shin-Jung Lee; Yung-Ching Liu
Journal:  J Clin Microbiol       Date:  2015-12-16       Impact factor: 5.948

8.  Interactions between glycopeptides and beta-lactams against isogenic pairs of teicoplanin-susceptible and -resistant strains of Staphylococcus haemolyticus.

Authors:  Carla Vignaroli; Francesca Biavasco; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.